Chen Y, Fu Y, Wang S, Chen P, Pei Y, Zhang J
Cardiovasc Diabetol. 2022; 21(1):252.
PMID: 36397150
PMC: 9682485.
DOI: 10.1186/s12933-022-01668-5.
Sahu A, Goel P, Khanna R, Kumar S, Kapoor A, Tewari S
Indian J Nephrol. 2022; 32(3):247-255.
PMID: 35814328
PMC: 9267084.
DOI: 10.4103/ijn.IJN_418_20.
Miao S, Xue Z, Zhang Y, Zhang H, Che J, Liu T
Med Sci Monit. 2021; 27:e929115.
PMID: 33927176
PMC: 8095087.
DOI: 10.12659/MSM.929115.
Shafaei-Bajestani N, Talasaz A, Salarifar M, Pourhosseini H, Sadri F, Jalali A
J Res Pharm Pract. 2019; 8(2):75-82.
PMID: 31367642
PMC: 6636420.
DOI: 10.4103/jrpp.JRPP_18_78.
Aslanabadi N, Afsar Gharebagh R, Moharramzadeh S, Entezari-Maleki T
Int Urol Nephrol. 2019; 51(4):699-705.
PMID: 30830654
DOI: 10.1007/s11255-019-02104-6.
Cystatin C as a Candidate Biomarker of Cardiovascular Outcomes: Too Near, but too Far from Reality.
de Carvalho L, Silva T, Coelho-Filho O
Arq Bras Cardiol. 2018; 111(6):808-809.
PMID: 30517376
PMC: 6263453.
DOI: 10.5935/abc.20180226.
Glomerular filtration decrease after diagnostic cardiac catheterisation in children with congenital cardiac malformation - the role of serum creatinine, cystatin C, neutrophil gelatinase and urine output monitoring.
Tkaczyk M, Tomczyk D, Jander A, Goreczny S, Moszura T, Dryzek P
Postepy Kardiol Interwencyjnej. 2018; 14(1):67-74.
PMID: 29743906
PMC: 5939547.
DOI: 10.5114/aic.2018.74357.
The impact of N-acetylcysteine and ascorbic acid in contrast-induced nephropathy in critical care patients: an open-label randomized controlled study.
Palli E, Makris D, Papanikolaou J, Garoufalis G, Tsilioni I, Zygoulis P
Crit Care. 2017; 21(1):269.
PMID: 29089038
PMC: 5664844.
DOI: 10.1186/s13054-017-1862-3.
Nephroprotective Effects of L-Carnitine against Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention: A Randomized Open-Labeled Clinical Trial.
Mohammadi M, Talasaz A, Alidoosti M, Pour Hosseini H, Gholami K, Jalali A
J Tehran Heart Cent. 2017; 12(2):57-64.
PMID: 28828020
PMC: 5558056.
Potential Role of Allopurinol in Preventing Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention: A Randomized Placebo-Controlled Trial.
Ghelich Khan Z, Talasaz A, Pourhosseini H, Hosseini K, Ansari M, Jalali A
Clin Drug Investig. 2017; 37(9):853-860.
PMID: 28608311
DOI: 10.1007/s40261-017-0542-z.
Neutrophil gelatinase-associated lipocalin (NGAL) fails as an early predictor of contrast induced nephropathy in chronic kidney disease (ANTI-CI-AKI study).
Ribitsch W, Schilcher G, Quehenberger F, Pilz S, Portugaller R, Truschnig-Wilders M
Sci Rep. 2017; 7:41300.
PMID: 28128223
PMC: 5269674.
DOI: 10.1038/srep41300.
Significance of Cystatin C for Early Diagnosis of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography.
Wang M, Zhang L, Yue R, You G, Zeng R
Med Sci Monit. 2016; 22:2956-61.
PMID: 27548357
PMC: 5004983.
DOI: 10.12659/msm.897241.
Contrast-induced nephropathy following angiography and cardiac interventions.
Rear R, Bell R, Hausenloy D
Heart. 2016; 102(8):638-48.
PMID: 26857214
PMC: 4819627.
DOI: 10.1136/heartjnl-2014-306962.
The role of neutrophil-gelatinase-associated lipocalin in early diagnosis of contrast nephropathy.
Khatami M, Sabbagh M, Nikravan N, Khazaeipour Z, Boroumand M, Sadeghian S
Indian J Nephrol. 2015; 25(5):292-6.
PMID: 26628795
PMC: 4588325.
DOI: 10.4103/0971-4065.147370.
Midkine: a novel and early biomarker of contrast-induced acute kidney injury in patients undergoing percutaneous coronary interventions.
Malyszko J, Bachorzewska-Gajewska H, Koc-Zorawska E, Malyszko J, Kobus G, Dobrzycki S
Biomed Res Int. 2015; 2015:879509.
PMID: 25629054
PMC: 4299314.
DOI: 10.1155/2015/879509.
NGAL Usefulness in the Intensive Care Unit Three Hours after Cardiac Surgery.
Delcroix G, Gillain N, Moonen M, Radermacher L, Damas F, Minon J
ISRN Nephrol. 2014; 2013:865164.
PMID: 24967231
PMC: 4045423.
DOI: 10.5402/2013/865164.
Early trends in cystatin C and outcomes in patients with cirrhosis and acute kidney injury.
Belcher J, Sanyal A, Garcia-Tsao G, Ansari N, Coca S, Shlipak M
Int J Nephrol. 2014; 2014:708585.
PMID: 24757564
PMC: 3976933.
DOI: 10.1155/2014/708585.
Serum lipocalin-2 levels positively correlate with coronary artery disease and metabolic syndrome.
Ni J, Ma X, Zhou M, Pan X, Tang J, Hao Y
Cardiovasc Diabetol. 2013; 12:176.
PMID: 24359145
PMC: 3878105.
DOI: 10.1186/1475-2840-12-176.
Accuracy of plasma neutrophil gelatinase-associated lipocalin in the early diagnosis of contrast-induced acute kidney injury in critical illness.
Valette X, Savary B, Nowoczyn M, Daubin C, Pottier V, Terzi N
Intensive Care Med. 2013; 39(5):857-65.
PMID: 23361630
DOI: 10.1007/s00134-013-2826-y.
Neutrophil gelatinase-associated lipocalin in the diagnosis of type 1 cardio-renal syndrome in the general ward.
Alvelos M, Pimentel R, Pinho E, Gomes A, Lourenco P, Teles M
Clin J Am Soc Nephrol. 2010; 6(3):476-81.
PMID: 21115620
PMC: 3082403.
DOI: 10.2215/CJN.06140710.